(Q52547431)

English

[Antegren (natalizumab). A promising new approach to therapy of multiple sclerosis]

scientific article published in June 2002

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12243004

retrieved

3 May 2018

reference URL

http://europepmc.org/abstract/MED/12243004

title

[Antegren (natalizumab). A promising new approach to therapy of multiple sclerosis] (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12243004

retrieved

3 May 2018

reference URL

http://europepmc.org/abstract/MED/12243004

author name string

Kümpfel T

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12243004

retrieved

3 May 2018

reference URL

http://europepmc.org/abstract/MED/12243004

Heydari N

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12243004

retrieved

3 May 2018

reference URL

http://europepmc.org/abstract/MED/12243004

Hohlfeld R

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12243004

retrieved

3 May 2018

reference URL

http://europepmc.org/abstract/MED/12243004

publication date

1 June 2002

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12243004

retrieved

3 May 2018

reference URL

http://europepmc.org/abstract/MED/12243004

published in

Der Nervenarzt

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12243004

retrieved

3 May 2018

reference URL

http://europepmc.org/abstract/MED/12243004

volume

73

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12243004

retrieved

3 May 2018

reference URL

http://europepmc.org/abstract/MED/12243004

issue

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12243004

retrieved

3 May 2018

reference URL

http://europepmc.org/abstract/MED/12243004

page(s)

552-555

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12243004

retrieved

3 May 2018

reference URL

http://europepmc.org/abstract/MED/12243004

exact match

https://scigraph.springernature.com/pub.10.1007/s00115-002-1314-3

0 references

Identifiers

DOI

10.1007/S00115-002-1314-3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12243004

retrieved

3 May 2018

reference URL

http://europepmc.org/abstract/MED/12243004

PubMed publication ID

12243004

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12243004

retrieved

3 May 2018

reference URL

http://europepmc.org/abstract/MED/12243004

(Q52547431)

[Antegren (natalizumab). A promising new approach to therapy of multiple sclerosis]

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)